Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
作者： Di Li , Tianqi Su , Lili Ma , Feng Yin , Weiguo Xu
DOI: 10.1016/J.EJMECH.2020.112367
关键词:
摘要: … The pH sensitivity will endow the polysaccharide-di-drugs conjugates with the high-selective intracellular release of two drugs in the combination cancer chemotherapy. …
sci-hub.se 参考文章(30)
Weiguo Xu, Jianxun Ding, Chunsheng Xiao, Lingyu Li, Xiuli Zhuang, Xuesi Chen, Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic. Biomaterials. ,vol. 54, pp. 72- 86 ,(2015) , 10.1016/J.BIOMATERIALS.2015.03.021
Francesca Greco, María J. Vicent, Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines Advanced Drug Delivery Reviews. ,vol. 61, pp. 1203- 1213 ,(2009) , 10.1016/J.ADDR.2009.05.006
Helmut Ringsdorf, Structure and properties of pharmacologically active polymers Journal of Polymer Science: Polymer Symposia. ,vol. 51, pp. 135- 153 ,(1975) , 10.1002/POLC.5070510111
D. Chen, M. Frezza, S. Schmitt, J. Kanwar, Q. P. Dou, Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives Current Cancer Drug Targets. ,vol. 11, pp. 239- 253 ,(2011) , 10.2174/156800911794519752
Weiguo Xu, Jianxun Ding, Lingyu Li, Chunsheng Xiao, Xiuli Zhuang, Xuesi Chen, Acid-labile boronate-bridged dextran–bortezomib conjugate with up-regulated hypoxic tumor suppression Chemical Communications. ,vol. 51, pp. 17775- 17776 ,(2015) , 10.1039/C5CC01371B
Laura Gatti, Valentina Zuco, Nadia Zaffaroni, Paola Perego, Drug Combinations with Proteasome Inhibitors in Antitumor Therapy Current Pharmaceutical Design. ,vol. 19, pp. 4094- 4114 ,(2013) , 10.2174/1381612811319220015
Nicholas Mitsiades, Constantine S. Mitsiades, Paul G. Richardson, Vassiliki Poulaki, Yu-Tzu Tai, Dharminder Chauhan, Galinos Fanourakis, Xuesong Gu, Charles Bailey, Marie Joseph, Towia A. Libermann, Robert Schlossman, Nikhil C. Munshi, Teru Hideshima, Kenneth C. Anderson, The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications. Blood. ,vol. 101, pp. 2377- 2380 ,(2003) , 10.1182/BLOOD-2002-06-1768
Xin Pang, Yue Jiang, Qicai Xiao, Albert Wingnang Leung, Heyu Hua, Chuanshan Xu, pH-responsive polymer-drug conjugates: Design and progress. Journal of Controlled Release. ,vol. 222, pp. 116- 129 ,(2016) , 10.1016/J.JCONREL.2015.12.024
Di Li, Jianxun Ding, Xiuli Zhuang, Li Chen, Xuesi Chen, Drug binding rate regulates the properties of polysaccharide prodrugs Journal of Materials Chemistry B. ,vol. 4, pp. 5167- 5177 ,(2016) , 10.1039/C6TB00991C
Di Li, Weiguo Xu, Pengqiang Li, Jianxun Ding, Zhiliang Cheng, Li Chen, Lesan Yan, Xuesi Chen, Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma. Molecular Pharmaceutics. ,vol. 13, pp. 4231- 4235 ,(2016) , 10.1021/ACS.MOLPHARMACEUT.6B00747